Cynthia S Chiu, MD
Ophthalmology · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 25 years
- Stanford University School of Medicine, 2001
Offices
1 location
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chiu’s office at (510) 836-2122 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A96867 · Current
Licensed to practise in California · since 2006 · expires 2027-09-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- 481 ASC Project LLC dba EYE MD Laser & Surgery Center, LLCAmbulatory Surgery Center · Oakland, CA4.71% owner since 2021 · accredited by AAAHCAccreditation Renewed5 inspections, 1 with deficiencies · last 2025-09-08
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$328,755
Medicare paid this office $328,755 for 1,082 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 701 | $80,616 | $112 |
| Removal of cataract with insertion of prosthetic lens | 64 | $50,549 | $516 |
| Established patient problem focused exam of visual system | 471 | $45,212 | $79 |
| Complex removal of cataract with insertion of prosthetic lens | 33 | $33,112 | $705 |
| Removal of recurring cataract in lens capsule using a laser | 61 | $23,615 | $303 |
See all 16 services
| Established patient complete exam of visual system | 701 | $80,616 | $112 |
| Removal of cataract with insertion of prosthetic lens | 64 | $50,549 | $516 |
| Established patient problem focused exam of visual system | 471 | $45,212 | $79 |
| Complex removal of cataract with insertion of prosthetic lens | 33 | $33,112 | $705 |
| Removal of recurring cataract in lens capsule using a laser | 61 | $23,615 | $303 |
| Exam of visual field with extended testing | 277 | $16,643 | $60 |
| New patient visit (45+ min) | 79 | $10,681 | $135 |
| Exam of the internal drainage system of eye | 391 | $10,155 | $25 |
| Return visit (30+ min) | 82 | $9,563 | $114 |
| Photography of the retina | 252 | $8,287 | $33 |
| Imaging of optic nerve | 252 | $8,131 | $32 |
| New patient complete exam of visual system | 63 | $8,121 | $129 |
| Imaging of retina | 166 | $6,236 | $37 |
| Measurement of corneal curvature and depth of eye | 91 | $5,101 | $35 |
| Removal of eyelashes using forceps | 25 | $701 | $20 |
| Ultrasound scan of cornea to determine thickness | 54 | $526 | $10 |
Procedures Medicare counted
| Cataract surgery | 212 | More than 85% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Complex removal of cataract with insertion of prosthetic lens | 67 | 75 | 95 | 79 | 52 | 47 |
| Removal of cataract with insertion of prosthetic lens | 68 | 38 | 55 | 37 | 68 | 98 |
| Removal of recurring cataract in lens capsule using a laser | 34 | 20 | 34 | 52 | 52 | 78 |
| Removal of eyelashes using forceps | 32 | 36 | 64 | 41 | 31 | 35 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,082 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 19% · Women 62% · Also on Medicaid 34% · Health risk score 1.03. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 70% · Diabetes 34% · Chronic kidney disease 23% · Coronary heart disease 18% · Cancer 15% · Depression 13% · Atrial fibrillation 11% · Heart failure 8% · COPD 7% · Dementia 6% · Stroke 6%.
The office billed $448,445, Medicare allowed $441,533 and paid $328,755; for 3,384 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,082 | 3,384 | 77 | 1.03 | $448,445 | $328,755 |
| 2023 | 1,145 | 3,506 | 77 | 1.01 | $427,272 | $309,271 |
| 2022 | 1,022 | 3,563 | 77 | 0.96 | $419,068 | $305,815 |
| 2021 | 1,000 | 3,441 | 77 | 1.04 | $437,848 | $325,099 |
| 2020 | 795 | 2,443 | 77 | 1.11 | $316,617 | $234,144 |
| 2019 | 939 | 3,574 | 77 | 1.19 | $419,472 | $309,389 |
| 2018 | 846 | 3,567 | 78 | 1.21 | $367,519 | $271,152 |
| 2017 | 774 | 3,207 | 78 | 1.16 | $352,668 | $246,299 |
| 2016 | 202 | 550 | 77 | 0.86 | $64,122 | $49,312 |
| 2015 | 366 | 1,261 | 75 | 1.23 | $828,693 | $129,947 |
| 2014 | 383 | 1,327 | 75 | 1.19 | $909,284 | $145,369 |
| 2013 | 375 | 1,306 | 74 | 1.19 | $777,821 | $128,411 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Established patient complete exam of visual system | 710 | $80,915 | $112 |
| Established patient problem focused exam of visual system | 462 | $49,904 | $82 |
| Complex removal of cataract with insertion of prosthetic lens | 35 | $36,436 | $701 |
| Removal of cataract with insertion of prosthetic lens | 47 | $34,898 | $513 |
| New patient complete exam of visual system | 138 | $16,970 | $123 |
| Removal of recurring cataract in lens capsule using a laser | 40 | $15,569 | $299 |
| Exam of visual field with extended testing | 261 | $15,408 | $58 |
| Exam of the internal drainage system of eye | 400 | $10,295 | $25 |
| Imaging of optic nerve | 262 | $8,660 | $32 |
| Photography of the retina | 239 | $7,750 | $32 |
| Measurement of corneal curvature and depth of eye | 88 | $4,947 | $37 |
| Imaging of retina | 116 | $4,383 | $37 |
| Short return visit (20+ min) | 43 | $3,445 | $75 |
| New patient visit (45+ min) | 27 | $3,232 | $120 |
| Return visit (30+ min) | 35 | $3,007 | $86 |
| Extended exam of the back part of the eye with optic nerve drawing | 208 | $2,761 | $13 |
| Removal of eyelashes using forceps | 21 | $678 | $22 |
| Ultrasound scan of cornea to determine thickness | 50 | $477 | $10 |
2022: 15 services
| Established patient complete exam of visual system | 711 | $79,886 | $110 |
| Complex removal of cataract with insertion of prosthetic lens | 56 | $55,429 | $702 |
| Established patient problem focused exam of visual system | 483 | $50,670 | $79 |
| Removal of cataract with insertion of prosthetic lens | 25 | $18,946 | $512 |
| New patient complete exam of visual system | 144 | $18,589 | $129 |
| Exam of visual field with extended testing | 288 | $17,184 | $58 |
| Removal of recurring cataract in lens capsule using a laser | 44 | $15,531 | $299 |
| Imaging of optic nerve | 316 | $10,619 | $33 |
| Exam of the internal drainage system of eye | 377 | $9,510 | $25 |
| Photography of the retina | 251 | $8,129 | $32 |
| Measurement of corneal curvature and depth of eye | 81 | $4,717 | $39 |
| Extended exam of the back part of the eye with optic nerve drawing | 315 | $4,337 | $14 |
| Imaging of retina | 71 | $2,748 | $38 |
| Removal of eyelashes using forceps | 28 | $828 | $20 |
| Ultrasound scan of cornea to determine thickness | 53 | $508 | $10 |
2021: 16 services
| Established patient complete exam of visual system | 635 | $71,057 | $111 |
| Complex removal of cataract with insertion of prosthetic lens | 61 | $66,931 | $705 |
| Established patient problem focused exam of visual system | 492 | $52,503 | $80 |
| Removal of cataract with insertion of prosthetic lens | 35 | $28,502 | $518 |
| New patient complete exam of visual system | 205 | $27,759 | $135 |
| Exam of visual field with extended testing | 225 | $13,763 | $61 |
| Imaging of optic nerve | 295 | $10,391 | $35 |
| Removal of recurring cataract in lens capsule using a laser | 25 | $10,216 | $300 |
| Exam of the internal drainage system of eye | 366 | $9,242 | $25 |
| Photography of the retina | 236 | $8,425 | $35 |
| Internal insertion of eye fluid drainage device | 15 | $7,134 | $297 |
| Measurement of corneal curvature and depth of eye | 92 | $6,470 | $43 |
| Extended exam of the back part of the eye with optic nerve drawing | 233 | $3,243 | $14 |
| Imaging of retina | 53 | $2,075 | $37 |
| Removal of eyelashes using forceps | 42 | $1,364 | $21 |
| Ultrasound scan of cornea to determine thickness | 68 | $687 | $10 |
2020: 15 services
| Established patient complete exam of visual system | 506 | $55,502 | $109 |
| Complex removal of cataract with insertion of prosthetic lens | 51 | $53,528 | $714 |
| Established patient problem focused exam of visual system | 347 | $37,031 | $81 |
| Removal of cataract with insertion of prosthetic lens | 24 | $19,807 | $521 |
| New patient complete exam of visual system | 119 | $16,026 | $135 |
| Exam of visual field with extended testing | 179 | $11,078 | $62 |
| Imaging of optic nerve | 198 | $6,937 | $35 |
| Photography of the retina | 165 | $6,909 | $42 |
| Exam of the internal drainage system of eye | 269 | $6,881 | $25 |
| Removal of recurring cataract in lens capsule using a laser | 16 | $6,104 | $305 |
| Measurement of corneal curvature and depth of eye | 72 | $4,492 | $44 |
| Extended exam of the back part of the eye with optic nerve drawing | 154 | $2,256 | $15 |
| Imaging of retina | 28 | $1,074 | $38 |
| Removal of eyelashes using forceps | 24 | $1,043 | $29 |
| Ultrasound scan of cornea to determine thickness | 51 | $546 | $10 |
2019: 17 services
| Established patient complete exam of visual system | 545 | $60,828 | $110 |
| Established patient problem focused exam of visual system | 460 | $50,375 | $79 |
| Complex removal of cataract with insertion of prosthetic lens | 45 | $49,756 | $743 |
| Removal of cataract with insertion of prosthetic lens | 51 | $41,078 | $604 |
| New patient complete exam of visual system | 159 | $19,948 | $125 |
| Photography of the retina | 313 | $15,562 | $50 |
| Exam of visual field with extended testing | 221 | $13,815 | $62 |
| Examination of eye by ophthalmoscope with retinal drawing | 282 | $11,001 | $23 |
| Removal of recurring cataract in lens capsule using a laser | 27 | $9,950 | $293 |
| Imaging of optic nerve | 285 | $9,783 | $34 |
| Exam of the internal drainage system of eye | 309 | $7,858 | $25 |
| Measurement of corneal curvature and depth of eye | 104 | $7,251 | $51 |
| Examination of eye by ophthalmoscope with retinal drawing | 85 | $3,522 | $26 |
| Short return visit (20+ min) | 38 | $2,997 | $67 |
| Imaging of retina | 34 | $1,377 | $39 |
| Removal of eyelashes using forceps | 26 | $1,091 | $34 |
| Ultrasound scan of cornea to determine thickness | 41 | $457 | $11 |
2018: 17 services
| Established patient complete exam of visual system | 476 | $54,253 | $112 |
| Established patient problem focused exam of visual system | 469 | $51,775 | $79 |
| Complex removal of cataract with insertion of prosthetic lens | 28 | $32,179 | $748 |
| New patient complete exam of visual system | 195 | $25,842 | $133 |
| Removal of cataract with insertion of prosthetic lens | 22 | $20,009 | $606 |
| Photography of the retina | 341 | $19,113 | $56 |
| Exam of visual field with extended testing | 245 | $15,048 | $61 |
| Imaging of optic nerve | 312 | $10,737 | $34 |
| Examination of eye by ophthalmoscope with retinal drawing | 262 | $10,212 | $23 |
| Exam of the internal drainage system of eye | 333 | $8,092 | $24 |
| Measurement of corneal curvature and depth of eye | 74 | $5,909 | $60 |
| Removal of recurring cataract in lens capsule using a laser | 18 | $5,723 | $301 |
| Examination of eye by ophthalmoscope with retinal drawing | 122 | $4,764 | $26 |
| Removal of eyelashes using forceps | 35 | $2,005 | $44 |
| Short return visit (20+ min) | 22 | $1,505 | $68 |
| Ultrasound scan of cornea to determine thickness | 81 | $1,122 | $14 |
| Imaging of retina | 22 | $873 | $40 |
2017: 15 services
| Established patient problem focused exam of visual system | 448 | $54,807 | $75 |
| Established patient complete exam of visual system | 393 | $43,672 | $109 |
| Complex removal of cataract with insertion of prosthetic lens | 24 | $29,010 | $725 |
| Removal of cataract with insertion of prosthetic lens | 32 | $22,136 | $583 |
| New patient complete exam of visual system | 178 | $22,003 | $124 |
| Photography of the retina | 295 | $18,687 | $63 |
| Exam of visual field with extended testing | 215 | $13,333 | $61 |
| Imaging of optic nerve | 271 | $9,084 | $34 |
| Exam of the internal drainage system of eye | 299 | $7,349 | $24 |
| Examination of eye by ophthalmoscope with retinal drawing | 156 | $5,824 | $24 |
| Examination of eye by ophthalmoscope with retinal drawing | 157 | $5,667 | $23 |
| Measurement of corneal curvature and depth of eye | 51 | $4,234 | $56 |
| Removal of eyelashes using forceps | 30 | $1,684 | $51 |
| Ultrasound scan of cornea to determine thickness | 92 | $1,169 | $13 |
| Imaging of retina | 21 | $813 | $39 |
2016: 11 services
| Removal of cataract with insertion of prosthetic lens | 13 | $10,425 | $579 |
| Established patient problem focused exam of visual system | 105 | $9,081 | $78 |
| Established patient complete exam of visual system | 61 | $6,762 | $109 |
| Photography of the retina | 42 | $3,138 | $73 |
| New patient complete exam of visual system | 24 | $2,975 | $124 |
| Exam of visual field with extended testing | 33 | $2,006 | $61 |
| Measurement of corneal curvature and depth of eye | 24 | $1,626 | $54 |
| Examination of eye by ophthalmoscope with retinal drawing | 41 | $1,455 | $24 |
| Imaging of optic nerve | 36 | $1,402 | $39 |
| Exam of the internal drainage system of eye | 51 | $1,236 | $24 |
| Ultrasound scan of cornea to determine thickness | 48 | $639 | $13 |
2015: 14 services
| Complex removal of cataract with insertion of prosthetic lens | 44 | $46,324 | $747 |
| Removal of cataract with insertion of prosthetic lens | 47 | $32,477 | $601 |
| Established patient complete exam of visual system | 198 | $12,797 | $63 |
| Established patient problem focused exam of visual system | 163 | $9,238 | $41 |
| Removal of recurring cataract in lens capsule using a laser | 21 | $7,178 | $299 |
| New patient complete exam of visual system | 63 | $4,062 | $64 |
| Measurement of corneal curvature and depth of eye | 48 | $2,804 | $29 |
| Imaging of optic nerve | 114 | $2,725 | $23 |
| Exam of visual field with extended testing | 82 | $2,465 | $25 |
| Examination of eye by ophthalmoscope with retinal drawing | 63 | $1,634 | $16 |
| Examination of eye by ophthalmoscope with retinal drawing | 45 | $1,134 | $18 |
| Imaging of retina | 32 | $724 | $21 |
| Exam of the internal drainage system of eye | 44 | $716 | $16 |
| Ultrasound scan of cornea to determine thickness | 24 | $195 | $8 |
2014: 14 services
| Removal of cataract with insertion of prosthetic lens | 84 | $67,774 | $611 |
| Complex removal of cataract with insertion of prosthetic lens | 29 | $26,339 | $753 |
| Established patient complete exam of visual system | 201 | $13,604 | $65 |
| Established patient problem focused exam of visual system | 159 | $9,101 | $42 |
| New patient complete exam of visual system | 86 | $6,595 | $77 |
| Removal of recurring cataract in lens capsule using a laser | 13 | $5,056 | $297 |
| Measurement of corneal curvature and depth of eye | 77 | $2,988 | $29 |
| Exam of visual field with extended testing | 73 | $2,448 | $24 |
| Imaging of optic nerve | 76 | $2,118 | $25 |
| Examination of eye by ophthalmoscope with retinal drawing | 77 | $1,912 | $19 |
| Examination of eye by ophthalmoscope with retinal drawing | 81 | $1,857 | $17 |
| Imaging of retina | 47 | $1,592 | $27 |
| Exam of the internal drainage system of eye | 39 | $683 | $17 |
| Ultrasound scan of cornea to determine thickness | 27 | $226 | $8 |
2013: 14 services
| Removal of cataract with insertion of prosthetic lens | 59 | $51,157 | $609 |
| Complex removal of cataract with insertion of prosthetic lens | 27 | $24,266 | $758 |
| Established patient complete exam of visual system | 233 | $16,576 | $67 |
| New patient complete exam of visual system | 88 | $7,425 | $84 |
| Established patient problem focused exam of visual system | 124 | $7,183 | $46 |
| Examination of eye by ophthalmoscope with retinal drawing | 110 | $3,459 | $19 |
| Examination of eye by ophthalmoscope with retinal drawing | 71 | $2,148 | $17 |
| Measurement of corneal curvature and depth of eye | 59 | $2,120 | $29 |
| Imaging of optic nerve | 77 | $1,923 | $24 |
| Exam of visual field with extended testing | 60 | $1,614 | $26 |
| Imaging of retina | 42 | $1,162 | $25 |
| Exam of the internal drainage system of eye | 35 | $754 | $19 |
| Photography of the retina | 13 | $279 | $21 |
| Ultrasound scan of cornea to determine thickness | 27 | $233 | $9 |
Medicaid work
$5,140 in 2024
Medicaid paid $5,140 for 192 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 97 | $3,468 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 41 | $1,226 |
| GONIOSCOPY | 40 | $290 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 14 | $156 |
| 2024 | 192 | 4 | 17 | $5,140 |
| 2023 | 265 | 5 | 24 | $5,665 |
| 2022 | 104 | 3 | 24 | $1,501 |
| 2021 | 210 | 4 | 20 | $7,731 |
See the largest Medicaid services in earlier years
2023
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 119 | $3,791 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 90 | $1,445 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 16 | $292 |
| GONIOSCOPY | 26 | $136 |
| Bilateral extended ophthalmoscopy with drawing of optic nerve, with interpretation and report | 14 | $0 |
2022
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 71 | $1,494 |
| Bilateral extended ophthalmoscopy with drawing of optic nerve, with interpretation and report | 16 | $8 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 17 | $0 |
2021
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 72 | $4,273 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 84 | $2,243 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 42 | $1,168 |
| GONIOSCOPY | 12 | $48 |
Drugs they prescribed that Part D paid
$284,937
Pharmacies billed $284,937 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,866) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
1,018 generic and 848 brand-name prescriptions · $284,937 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cyclosporine | 99 | $56,590 | $572 |
| Restasis | 38 | $47,113 | $1,240 |
| Lumigan | 51 | $28,936 | $567 |
| Xiidra | 20 | $27,828 | $1,391 |
| Cequa | 16 | $16,103 | $1,006 |
See all 21 drugs
| Cyclosporine | 99 | $56,590 | $572 |
| Restasis | 38 | $47,113 | $1,240 |
| Lumigan | 51 | $28,936 | $567 |
| Xiidra | 20 | $27,828 | $1,391 |
| Cequa | 16 | $16,103 | $1,006 |
| Rocklatan | 18 | $12,547 | $697 |
| Tyrvaya | 11 | $11,610 | $1,055 |
| Prednisolone Acetate | 205 | $9,747 | $48 |
| Latanoprost | 428 | $6,939 | $16 |
| Difluprednate | 33 | $5,658 | $171 |
| Alphagan P | 11 | $5,412 | $492 |
| Ketorolac Tromethamine | 199 | $5,014 | $25 |
| Brimonidine Tartrate-Timolol | 27 | $3,787 | $140 |
| Moxifloxacin | 188 | $3,698 | $20 |
| Brinzolamide | 19 | $3,225 | $170 |
| Timolol Maleate | 164 | $3,038 | $19 |
| Dorzolamide-Timolol | 99 | $1,809 | $18 |
| Brimonidine | 60 | $1,793 | $30 |
| Neomycin-Polymyxin-Dexameth | 61 | $778 | $13 |
| Fluorometholone | 12 | $702 | $59 |
| Dorzolamide | 11 | $104 | $9 |
Year by year
| 2024 | 1,866 | 459 | 0% (0) | 45% | $284,937 |
| 2023 | 1,831 | 415 | 0% (0) | 45% | $395,564 |
| 2022 | 1,793 | 420 | 0% (0) | 49% | $420,634 |
| 2021 | 1,852 | 413 | 0% (0) | 53% | $406,671 |
| 2020 | 1,838 | 413 | 0% (0) | 47% | $338,987 |
| 2019 | 1,978 | 449 | None | 45% | $352,087 |
| 2018 | 2,113 | 435 | None | 54% | $348,567 |
| 2017 | 1,940 | 406 | None | 53% | $272,204 |
| 2016 | 1,432 | 366 | None | 60% | $174,245 |
| 2015 | 754 | 139 | 0% (0) | 64% | $53,872 |
| 2014 | 926 | 184 | None | 66% | $70,731 |
| 2013 | 771 | 162 | 0% (0) | 67% | $64,152 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Restasis | 98 | $151,881 | $1,550 |
| Cyclosporine | 42 | $38,955 | $928 |
| Lumigan | 45 | $31,785 | $706 |
| Xiidra | 17 | $29,622 | $1,742 |
| Combigan | 35 | $18,789 | $537 |
| Latanoprost | 460 | $14,064 | $31 |
| Alphagan P | 18 | $11,584 | $644 |
| Prednisolone Acetate | 170 | $9,517 | $56 |
| Difluprednate | 48 | $7,802 | $163 |
| Simbrinza | 14 | $6,401 | $457 |
| Ketorolac Tromethamine | 176 | $6,382 | $36 |
| Brimonidine Tartrate-Timolol | 14 | $5,308 | $379 |
| Moxifloxacin | 171 | $5,255 | $31 |
| Timolol Maleate | 181 | $4,665 | $26 |
| Travoprost | 13 | $4,564 | $351 |
| Brimonidine | 66 | $4,006 | $61 |
| Dorzolamide-Timolol | 93 | $2,942 | $32 |
| Fluorometholone | 20 | $1,909 | $95 |
| Dorzolamide | 27 | $1,236 | $46 |
| Neomycin-Polymyxin-Dexameth | 40 | $529 | $13 |
2022: 23 drugs
| Restasis | 126 | $196,393 | $1,559 |
| Lumigan | 72 | $43,818 | $609 |
| Xiidra | 12 | $21,548 | $1,796 |
| Latanoprost | 495 | $16,685 | $34 |
| Cequa | 18 | $16,124 | $896 |
| Combigan | 29 | $15,968 | $551 |
| Alphagan P | 27 | $15,043 | $557 |
| Rocklatan | 11 | $8,682 | $789 |
| Prednisolone Acetate | 137 | $8,270 | $60 |
| Azopt | 14 | $7,667 | $548 |
| Simbrinza | 15 | $7,131 | $475 |
| Travoprost | 17 | $5,042 | $297 |
| Ketorolac Tromethamine | 125 | $4,539 | $36 |
| Brimonidine Tartrate-Timolol | 17 | $4,480 | $264 |
| Timolol Maleate | 184 | $4,397 | $24 |
| Dorzolamide-Timolol | 100 | $3,993 | $40 |
| Moxifloxacin | 115 | $3,622 | $31 |
| Olopatadine | 19 | $3,598 | $189 |
| Brimonidine | 55 | $2,316 | $42 |
| Fluorometholone | 27 | $2,165 | $80 |
| Dorzolamide | 26 | $978 | $38 |
| Azelastine | 14 | $813 | $58 |
| Neomycin-Polymyxin-Dexameth | 55 | $698 | $13 |
2021: 20 drugs
| Restasis | 100 | $151,597 | $1,516 |
| Lumigan | 69 | $39,172 | $568 |
| Xiidra | 23 | $38,395 | $1,669 |
| Cequa | 37 | $30,370 | $821 |
| Combigan | 53 | $20,723 | $391 |
| Latanoprost | 478 | $15,109 | $32 |
| Alphagan P | 29 | $14,526 | $501 |
| Azopt | 24 | $12,732 | $531 |
| Prednisolone Acetate | 155 | $9,432 | $61 |
| Travoprost | 26 | $8,655 | $333 |
| Simbrinza | 21 | $8,563 | $408 |
| Olopatadine | 50 | $8,163 | $163 |
| Brimonidine | 72 | $5,984 | $83 |
| Timolol Maleate | 184 | $5,133 | $28 |
| Ketorolac Tromethamine | 144 | $5,108 | $35 |
| Moxifloxacin | 132 | $3,869 | $29 |
| Dorzolamide-Timolol | 70 | $3,060 | $44 |
| Durezol | 14 | $2,947 | $210 |
| Neomycin-Polymyxin-Dexameth | 57 | $841 | $15 |
| Dorzolamide | 17 | $584 | $34 |
2020: 23 drugs
| Restasis | 53 | $77,184 | $1,456 |
| Lumigan | 65 | $33,780 | $520 |
| Xiidra | 21 | $31,769 | $1,513 |
| Travoprost | 65 | $20,029 | $308 |
| Azopt | 34 | $19,720 | $580 |
| Travatan Z | 40 | $18,545 | $464 |
| Alphagan P | 37 | $17,481 | $472 |
| Combigan | 31 | $16,370 | $528 |
| Latanoprost | 522 | $15,477 | $30 |
| Cequa | 16 | $10,209 | $638 |
| Olopatadine | 96 | $9,310 | $97 |
| Prednisolone Acetate | 112 | $7,010 | $63 |
| Pazeo | 17 | $6,554 | $386 |
| Brimonidine | 68 | $6,543 | $96 |
| Simbrinza | 13 | $5,545 | $427 |
| Dorzolamide-Timolol | 75 | $4,845 | $65 |
| Timolol Maleate | 202 | $4,501 | $22 |
| Ketorolac Tromethamine | 102 | $4,293 | $42 |
| Moxifloxacin | 106 | $4,000 | $38 |
| Tobradex | 12 | $2,861 | $238 |
| Dorzolamide | 29 | $970 | $33 |
| Neomycin-Polymyxin-Dexameth | 39 | $661 | $17 |
| Erythromycin | 12 | $179 | $15 |
2019: 22 drugs
| Restasis | 53 | $76,006 | $1,434 |
| Travatan Z | 125 | $58,316 | $467 |
| Lumigan | 52 | $26,077 | $501 |
| Xiidra | 16 | $23,299 | $1,456 |
| Alphagan P | 47 | $21,885 | $466 |
| Azopt | 40 | $21,789 | $545 |
| Latanoprost | 551 | $17,456 | $32 |
| Combigan | 28 | $15,634 | $558 |
| Restasis Multidose | 12 | $13,905 | $1,159 |
| Olopatadine | 56 | $10,472 | $187 |
| Prednisolone Acetate | 150 | $9,155 | $61 |
| Brimonidine | 70 | $6,919 | $99 |
| Moxifloxacin | 136 | $6,866 | $50 |
| Ketorolac Tromethamine | 145 | $4,760 | $33 |
| Timolol Maleate | 241 | $4,583 | $19 |
| Dorzolamide-Timolol | 65 | $3,991 | $61 |
| Simbrinza | 13 | $3,955 | $304 |
| Durezol | 19 | $3,753 | $198 |
| Dorzolamide | 44 | $1,540 | $35 |
| Neomycin-Polymyxin-Dexameth | 35 | $519 | $15 |
| Erythromycin | 17 | $233 | $14 |
| Polymyxin B Sul-Trimethoprim | 11 | $98 | $9 |
2018: 20 drugs
| Travatan Z | 148 | $64,314 | $435 |
| Restasis Multidose | 50 | $63,873 | $1,277 |
| Restasis | 25 | $28,669 | $1,147 |
| Azopt | 59 | $25,642 | $435 |
| Lumigan | 59 | $23,953 | $406 |
| Alphagan P | 51 | $22,565 | $442 |
| Latanoprost | 635 | $18,230 | $29 |
| Combigan | 36 | $16,606 | $461 |
| Brimonidine | 97 | $10,789 | $111 |
| Olopatadine | 43 | $8,656 | $201 |
| Prednisolone Acetate | 127 | $7,889 | $62 |
| Ketorolac Tromethamine | 108 | $6,870 | $64 |
| Pazeo | 15 | $6,058 | $404 |
| Simbrinza | 22 | $5,271 | $240 |
| Moxifloxacin | 95 | $4,918 | $52 |
| Xalatan | 13 | $4,360 | $335 |
| Timolol Maleate | 296 | $3,658 | $12 |
| Dorzolamide | 60 | $1,456 | $24 |
| Dorzolamide-Timolol | 62 | $1,317 | $21 |
| Neomycin-Polymyxin-Dexameth | 23 | $346 | $15 |
2017: 23 drugs
| Travatan Z | 157 | $62,654 | $399 |
| Alphagan P | 67 | $27,821 | $415 |
| Restasis | 27 | $19,252 | $713 |
| Azopt | 38 | $19,212 | $506 |
| Restasis Multidose | 14 | $18,475 | $1,320 |
| Latanoprost | 561 | $14,979 | $27 |
| Lumigan | 33 | $13,961 | $423 |
| Combigan | 44 | $13,236 | $301 |
| Brimonidine | 116 | $10,678 | $92 |
| Vigamox | 59 | $9,231 | $156 |
| Ketorolac Tromethamine | 97 | $8,346 | $86 |
| Prednisolone Acetate | 125 | $8,259 | $66 |
| Betoptic S | 19 | $7,990 | $421 |
| Pazeo | 18 | $5,308 | $295 |
| Xalatan | 15 | $4,289 | $286 |
| Pataday | 12 | $3,028 | $252 |
| Timolol Maleate | 254 | $2,994 | $12 |
| Moxifloxacin | 32 | $2,943 | $92 |
| Simbrinza | 14 | $2,594 | $185 |
| Durezol | 12 | $2,071 | $173 |
| Dorzolamide | 63 | $2,035 | $32 |
| Dorzolamide-Timolol | 77 | $1,967 | $26 |
| Neomycin-Polymyxin-Dexameth | 27 | $449 | $17 |
2016: 21 drugs
| Travatan Z | 112 | $38,858 | $347 |
| Alphagan P | 58 | $17,132 | $295 |
| Vigamox | 105 | $15,913 | $152 |
| Restasis | 30 | $14,622 | $487 |
| Combigan | 44 | $13,937 | $317 |
| Lumigan | 23 | $9,041 | $393 |
| Ketorolac Tromethamine | 117 | $8,503 | $73 |
| Latanoprost | 358 | $8,012 | $22 |
| Prednisolone Acetate | 115 | $7,875 | $68 |
| Brimonidine | 81 | $7,875 | $97 |
| Azopt | 17 | $5,933 | $349 |
| Betoptic S | 16 | $4,702 | $294 |
| Simbrinza | 19 | $3,367 | $177 |
| Durezol | 12 | $2,468 | $206 |
| Pataday | 15 | $2,454 | $164 |
| Pazeo | 12 | $2,219 | $185 |
| Timolol Maleate | 152 | $2,025 | $13 |
| Dorzolamide | 36 | $755 | $21 |
| Dorzolamide-Timolol | 25 | $721 | $29 |
| Neomycin-Polymyxin-Dexameth | 24 | $411 | $17 |
| Erythromycin | 11 | $152 | $14 |
2015: 11 drugs
| Travatan Z | 58 | $10,964 | $189 |
| Prednisolone Acetate | 88 | $9,096 | $103 |
| Ketorolac Tromethamine | 75 | $4,670 | $62 |
| Brimonidine | 44 | $4,509 | $102 |
| Azopt | 11 | $3,784 | $344 |
| Lumigan | 11 | $3,392 | $308 |
| Latanoprost | 232 | $2,986 | $13 |
| Travoprost | 12 | $1,024 | $85 |
| Polymyxin B Sul-Trimethoprim | 64 | $604 | $9 |
| Timolol Maleate | 30 | $384 | $13 |
| Diclofenac | 16 | $139 | $9 |
2014: 15 drugs
| Prednisolone Acetate | 156 | $15,777 | $101 |
| Travatan Z | 73 | $10,786 | $148 |
| Brimonidine | 68 | $7,080 | $104 |
| Lumigan | 29 | $6,810 | $235 |
| Restasis | 16 | $5,174 | $323 |
| Ketorolac Tromethamine | 83 | $4,168 | $50 |
| Latanoprost | 196 | $3,512 | $18 |
| Azopt | 18 | $3,497 | $194 |
| Alphagan P | 23 | $2,792 | $121 |
| Vigamox | 11 | $1,223 | $111 |
| Polymyxin B Sul-Trimethoprim | 104 | $1,133 | $11 |
| Dorzolamide | 16 | $785 | $49 |
| Epinastine | 11 | $706 | $64 |
| Timolol Maleate | 34 | $490 | $14 |
| Dorzolamide-Timolol | 14 | $277 | $20 |
2013: 14 drugs
| Travatan Z | 137 | $18,035 | $132 |
| Lumigan | 53 | $10,145 | $191 |
| Restasis | 16 | $6,168 | $386 |
| Prednisolone Acetate | 127 | $5,539 | $44 |
| Brimonidine | 42 | $5,382 | $128 |
| Alphagan P | 22 | $3,041 | $138 |
| Nevanac | 15 | $2,250 | $150 |
| Betoptic S | 12 | $2,030 | $169 |
| Azopt | 13 | $2,025 | $156 |
| Ketorolac Tromethamine | 49 | $1,530 | $31 |
| Latanoprost | 81 | $1,498 | $18 |
| Polymyxin B Sul-Trimethoprim | 89 | $1,034 | $12 |
| Timolol Maleate | 36 | $553 | $15 |
| Dorzolamide-Timolol | 11 | $267 | $24 |
Money from drug and device companies
$1,599 in 2025
| 2025 | 12 | 33 | None | $1,599 |
| 2024 | 12 | 35 | None | $2,271 |
| 2023 | 9 | 40 | None | $3,573 |
| 2022 | 11 | 47 | None | $2,920 |
| 2021 | 10 | 39 | None | $758 |
| 2020 | 10 | 21 | None | $421 |
| 2019 | 11 | 26 | None | $1,371 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Clareon | $1,131 | 14 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $117 | 5 payments
|
| Harrow Eye | Vevye | $65 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $46 | 2 payments
|
| Bausch & Lomb Americas | Miebo | $42 | 2 payments
|
| Sight Sciences | Omni Surgical System | $36 | 2 payments
|
See all 33 published payments
| Harrow Eye | Meals · 2025-11-18 | Vevye | $28 |
| Dompe US | Meals · 2025-10-29 | Oxervate | $27 |
| Tarsus Pharmaceuticals | Meals · 2025-10-27 | Xdemvy | $21 |
| Alcon Vision | Meals · 2025-10-23 | Unity | $21 |
| Alcon Vision | Meals · 2025-10-21 | Rocklatan | $31 |
| Alcon Vision | Meals · 2025-10-17 | Unity | $14 |
| Sun Pharmaceutical Industries | Meals · 2025-10-07 | Cequa | $22 |
| Alcon Vision | Meals · 2025-09-30 | Tryptyr | $23 |
| Abbvie | Meals · 2025-09-25 | Lumigan | $29 |
| Alcon Vision | Meals · 2025-09-24 | Clareon Panoptix Pro | $5 |
| Harrow Eye | Meals · 2025-09-23 | Vevye | $37 |
| Bausch & Lomb Americas | Meals · 2025-09-10 | Miebo | $21 |
| Alcon Vision | Meals · 2025-09-09 | Tryptyr | $8 |
| Alcon Vision | Meals · 2025-08-21 | Clareon Panoptix Pro | $20 |
| Alcon Vision | Meals · 2025-08-12 | Rocklatan | $27 |
| Sight Sciences | Meals · 2025-08-06 | Omni Surgical System | $18 |
| Alcon Vision | Meals · 2025-07-26 | Clareon Panoptix Pro | $75 |
| Alcon Vision | Meals · 2025-06-25 | Eysuvis | $22 |
| Tarsus Pharmaceuticals | Meals · 2025-06-18 | Xdemvy | $24 |
| Sight Sciences | Meals · 2025-06-17 | Omni Surgical System | $18 |
| Tarsus Pharmaceuticals | Meals · 2025-05-27 | Xdemvy | $25 |
| Bausch & Lomb Americas | Meals · 2025-05-27 | Miebo | $22 |
| Alcon Vision | Travel · 2025-05-16 | None | $710 |
| Alcon Vision | Meals · 2025-04-27 | Clareon | $35 |
| Alcon Vision | Meals · 2025-04-18 | Clareon | $79 |
| Tarsus Pharmaceuticals | Meals · 2025-04-01 | Xdemvy | $22 |
| Johnson & Johnson Surgical Vision | Meals · 2025-03-31 | Tecnis Iol | $15 |
| Mallinckrodt Hospital Products | Meals · 2025-03-25 | Acthar | $31 |
| Thea Pharma | Meals · 2025-03-04 | Iyuzeh | $23 |
| RxSight | Meals · 2025-02-21 | Rxsight Contact Lens | $36 |
| Tarsus Pharmaceuticals | Meals · 2025-02-18 | Xdemvy | $25 |
| Sun Pharmaceutical Industries | Meals · 2025-01-21 | Cequa | $24 |
| Alcon Vision | Meals · 2025-01-10 | Clareon | $61 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,271
| Alcon Vision | Hydrus Microstent | $1,512 | 5 payments
|
| Sun Pharmaceutical Industries | Cequa | $221 | 7 payments
|
| Abbvie | Lumigan | $145 | 5 payments
|
| Oyster Point Pharma | Tyrvaya | $116 | 6 payments
|
| Harrow Eye | Vevye | $85 | 3 payments
|
| Bausch & Lomb Americas | Miebo | $45 | 2 payments
|
| Thea Pharma | Iyuzeh | $43 | 2 payments
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $26 | 1 payment
|
| Krystal Biotech | Vyjuvek | $24 | 1 payment
|
| Glaukos | Radius | $24 | 1 payment
|
| Sight Sciences | Omni Surgical System | $17 | 1 payment
|
| RxSight | Rxsight Contact Lens | $14 | 1 payment
|
2023: $3,573
| Alcon Vision | Clareon | $2,813 | 7 payments
|
| AbbVie | Lumigan | $234 | 8 payments
|
| Oyster Point Pharma | Tyrvaya | $207 | 10 payments
|
| Sun Pharmaceutical Industries | Cequa | $114 | 5 payments
|
| Mallinckrodt Hospital Products | Acthar | $57 | 2 payments
|
| Bausch & Lomb Americas | Miebo | $53 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $53 | 2 payments
|
| New World Medical | None | $23 | 2 payments
|
| Thea Pharma | Iyuzeh | $20 | 1 payment
|
2022: $2,920
| Alcon Vision | Hydrus Microstent | $2,148 | 15 payments
|
| Mallinckrodt Hospital Products | Acthar | $231 | 5 payments
|
| Oyster Point Pharma | Tyrvaya | $128 | 8 payments
|
| Novartis Pharmaceuticals | Xiidra | $101 | 5 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $88 | 4 payments
|
| Sun Pharmaceutical Industries | Cequa | $65 | 3 payments
|
| Abbvie | Vuity | $50 | 2 payments
|
| Allergan | Restasis Multidose | $43 | 2 payments
|
| Bausch & Lomb Americas | Prolensa | $25 | 1 payment
|
| Glaukos | Istent Inject W | $22 | 1 payment
|
| Dompe US | Oxervate | $18 | 1 payment
|
2021: $758
| Ivantis | Hydrus Microstent | $127 | 5 payments
|
| Allergan | Lumigan | $125 | 7 payments
|
| Alcon Vision | Acrysof Iq Vivity Iol | $123 | 7 payments
|
| Bausch & Lomb a division of Bausch Health US | Lotemax Sm | $114 | 8 payments
|
| Novartis Pharmaceuticals | Xiidra | $76 | 4 payments
|
| Aerie Pharmaceuticals | Rocklatan | $65 | 3 payments
|
| Carl Zeiss Meditec | Cirrus Hd-Oct | $52 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $40 | 2 payments
|
| EyePoint Pharmaceuticals US | Yutiq | $20 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $16 | 1 payment
|
2020: $421
| Alcon Vision | Lensx | $87 | 4 payments
|
| Allergan | Durysta | $71 | 4 payments
|
| Aerie Pharmaceuticals | Rhopressa | $47 | 2 payments
|
| Novartis Pharmaceuticals | Xiidra | $44 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Prolensa | $41 | 2 payments
|
| Ivantis | Hydrus | $38 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $35 | 2 payments
|
| Akorn | Zioptan | $21 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $21 | 1 payment
|
| Eyevance Pharmaceuticals | Flarex | $17 | 1 payment
|
2019: $1,371
| Alcon Vision | Restor | $959 | 5 payments
|
| Novartis Pharmaceuticals | Travatan Z | $127 | 7 payments
|
| Bausch & Lomb a division of Bausch Health US | Lotemax | $64 | 3 payments
|
| Aerie Pharmaceuticals | Rocklatan | $43 | 3 payments
|
| Allergan | Combigan | $40 | 2 payments
|
| NotalVision | Foreseehome | $27 | 1 payment
|
| Alcon Research | None | $26 | 1 payment
|
| Akorn | Zioptan | $24 | 1 payment
|
| Shire North American Group | Xiidra | $23 | 1 payment
|
| Eyevance Pharmaceuticals | Flarex | $20 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $20 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1306852629
- Licence
- CA A96867California A96867: Current · expires 2027-09-30
- Trained
- Stanford University School of Medicine, 2001 · 25 years ago
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 491 30th St, Suite 201, Oakland, CA, 94609
- NPI first listed
- 2006-07-31
- NPI last updated
- 2016-01-26
This is when the NPI record was last certified, not a medical board exam.